tirzepatide affirm financing Weight Loss Program with HypoSpray® New Tirzepatide Access and Pricing

Patients will first need prior authorization -- prescribing clinicians will submit documentation proving the patient meets strict body mass index (BMI) and health condition requirements

If that makes sense You can use our calculator for this You can schedule a call with me here Yes

Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for glucose regulation, appetite signalling and metabolic research

Week 14: Rapid appetite suppression + increased energy expenditure Month 13: Fastest fat loss of any studied GLP-1 class Month 36: Largest body composition shifts in trials 4872 weeks: Average 2430% total body weight reduction Ask our San Ramon team about retatrutide availability at your consultation

Our team is committed to supporting you every step of the way to ensure your treatment is as comfortable and effective as possible

FDA-approved tirzepatide is available only as an injection